Homburger advised Santhera Pharmaceuticals Holding AG on the deal. Santhera Pharmaceuticals Holding AG (SIX: SANN) entered into a royalty monetization financing totaling up to USD 38...
You must be a Standard 1 Year member to access this content.
Schellenberg Wittmer advised Santhera Pharmaceuticals Holding AG on the operation. Schellenberg Wittmer advised Santhera Pharmaceuticals Holding AG on the sale of its Raxone®/idebenone business for all...
You must be a Standard 1 Year member to access this content.
Homburger advised Santhera on its reverse share split. Santhera Pharmaceuticals Holding AG (SIX: SANN) completed a 10:1 reverse split of its shares, which had been approved...
You must be a Standard 1 Year member to access this content.
Schellenberg Wittmer advises Santhera on license for North America for Vamorolone. Santhera Pharmaceuticals (SIX: SANN) has signed an exclusive license and collaboration agreement for vamorolone in...
You must be a Standard 1 Year member to access this content.
Homburger advised Santhera on the deal. Santhera Pharmaceuticals Holding AG (SIX: SANN) announced a private placement of shares and an amendment of its existing financing with...
You must be a Standard 1 Year member to access this content.
chellenberg Wittmer advised Santhera Pharmaceuticals on the deal. Swiss Biotech Santhera has entered an exclusive licence agreement with China-based Sperogenix Therapeutics for the development of Vamorolone...
You must be a Standard 1 Year member to access this content.
Homburger advised Santhera in this matter. Santhera Pharmaceuticals annouced a strengthening of its capital structure via placement of private convertible bonds of CHF 15 million and upsizing of...
You must be a Standard 1 Year member to access this content.
Pestalozzi advised H.C. Wainwright on the deal. Homburger advised Santhera. Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular...
You must be a Standard 1 Year member to access this content.
Homburger acted as transaction counsel to Santhera in this matter. Santhera Pharmaceuticals Holding AG announced the settlement of the first exchange offer for a convertible bond...
You must be a Standard 1 Year member to access this content.
